MARCH 2021 // Communication

We are excited to share a scientific publication about the beneficial effect of the prototype SERI WOBE437 in a clinically relevant mouse model of Multiple Sclerosis and transient spasticity.


The article is published on ACS Pharmacology & Translational Science as the result of collaborative work between the group of Prof. J. Gertsch and Prof. B. Engelhardt at the University of Bern under the leadership of Dr. Andrea Chicca.


Find out more https://pubs.acs.org/doi/10.1021/acsptsci.0c00214



Graphic: Reynoso-Moreno et al., 2021.

Recent Posts

See All

© 2019 Synendos Therapeutics, Inc. All Rights Reserved.

  • LinkedIn - cerchio grigio
  • Twitter - cerchio grigio